Anti-CD19 Antibody (Loncastuximab)
Catalog No.
F1374
Anti-CD19 Antibody (Loncastuximab)
Featured Products
Loncastuximab (RB4v1.2) is an anti-CD19 monoclonal antibody. Loncastuximab exhibits anti-tumor activity and has potential applications in non-Hodgkin lymphoma (NHL) including diffuse large B-cell lymphoma (DLBCL).
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
144.46 kDa
Dry ice
1875032-68-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
RB4V1.2
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P15391
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD19
Please avoid freeze-thaw cycles.